Investors & Media

Ionis announces proposed private placement of convertible notes

CARLSBAD, Calif. , June 6, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2028 (the “notes”) in a private placement

Read more
You are now leaving to visit